Table 2 Longitudinal association between metabolic parameters and incident psoriasis.
From: Impact of metabolic status on the incidence of psoriasis: a Korean nationwide cohort study
Cases | Person-years | Incidence ratea | HR (95% CI) | |||
|---|---|---|---|---|---|---|
Unadjusted | Age-, Sex-adjusted | MVa-adjusted | ||||
DM | 555 | 135,950 | 4.08 | 1.36 (1.25–1.48) | 1.14 (1.04–1.25) | 1.15 (1.05–1.26) |
HTN | 1,622 | 400,572 | 4.05 | 1.42 (1.33–1.50) | 1.15 (1.08–1.23) | 1.15 (1.08–1.24) |
Hyperlipidemia | 570 | 133,457 | 4.27 | 1.42 (1.31–1.55) | 1.24 (1.13–1.35) | 1.24 (1.13–1.36) |
BMI (kg/m2) | ||||||
<18.5 | 416 | 160,815 | 2.59a | 0.88 (0.79–0.97) | 0.93 (0.84–1.03) | 0.92 (0.83–1.03) |
18.5–22.9 | 4,328 | 1,464,854 | 2.96 | 1 | 1 | 1 |
23–24.9 | 2,701 | 856,269 | 3.15 | 1.07 (1.02–1.12) | 1.01 (0.96–1.06) | 1.01 (0.96–1.06) |
≥25 | 3,609 | 1,085,134 | 3.33 | 1.13 (1.08–1.18) | 1.05 (1.01–1.10) | 1.05 (1.00–1.10) |
Metabolic status | ||||||
MHNO | 4,159 | 1,605,863 | 2.6 | 1 | 1 | 1 |
MUNO | 3,286 | 876,075 | 3.8 | 1.45 (1.38–1.52) | 1.31 (1.24–1.38) | 1.29 (1.22–1.37) |
MHO | 1,152 | 445,914 | 2.6 | 1.00 (0.93–1.07) | 0.96 (0.89–1.02) | 0.95 (0.89–1.02) |
MUO | 2,457 | 639,220 | 3.8 | 1.48 (1.41–1.56) | 1.35 (1.28–1.42) | 1.33 (1.26–1.41) |
